Literature DB >> 2932135

Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism--an association.

C Symons, F Fortune, R A Greenbaum, P Dandona.   

Abstract

Left ventricular hypertrophy (symmetric, asymmetric, or hypertrophic cardiomyopathy) is an almost invariable accompaniment of primary hyperparathyroidism. Five of 18 patients with hypertrophic cardiomyopathy had raised serum concentrations of parathyroid hormone with normal serum calcium concentrations. Left ventricular hypertrophy did not occur in any of the six patients with hypercalcaemia alone. These relations suggest that parathyroid hormone rather than a rise in the extracellular calcium concentration is associated with a spectrum of left ventricular hypertrophy. All patients with increased circulating parathyroid hormone concentrations should have echocardiographic examination of the left ventricle. Conversely, parathyroid hormone concentrations should be measured in all patients with left ventricular hypertrophy from an unknown cause, especially those with hypertrophic cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932135      PMCID: PMC481943          DOI: 10.1136/hrt.54.5.539

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  11 in total

1.  Echocardiographic features of secondary left ventricular hypertrophy.

Authors:  D G Gibson; T A Traill; R J Hall; D J Brown
Journal:  Br Heart J       Date:  1979-01

2.  Subaortic stenosis and parathyroid adenoma.

Authors:  D Shander; F H Katz
Journal:  Ann Intern Med       Date:  1978-05       Impact factor: 25.391

3.  Hypercalcemia and idiopathic hypertrophic subaortic stenosis.

Authors:  K F McFarland; M A Stefadouros; A M Abdulla; D E McFarland
Journal:  Ann Intern Med       Date:  1978-01       Impact factor: 25.391

Review 4.  The role of calcium in the control of myocardial contractility: an update.

Authors:  G A Langer
Journal:  J Mol Cell Cardiol       Date:  1980-03       Impact factor: 5.000

5.  Detection and characterization of small midregion parathyroid hormone fragment(s) in normal and hyperparathyroid glands and sera by immunoextraction and region-specific radioimmunoassays.

Authors:  B A Roos; A W Lindall; D C Aron; J W Orf; M Yoon; M B Huber; J Pensky; J Ells; P W Lambert
Journal:  J Clin Endocrinol Metab       Date:  1981-10       Impact factor: 5.958

6.  M mode echocardiography in hypertrophic cardiomyopathy: diagnostic criteria and prediction of obstruction.

Authors:  Y L Doi; W J McKenna; J Gehrke; C M Oakley; J F Goodwin
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

7.  Parathyroid ablation in dystrophic hamsters. Effects on Ca content and histology of heart, diaphragm, and rectus femoris.

Authors:  G M Palmieri; D F Nutting; S K Bhattacharya; T E Bertorini; J C Williams
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

8.  Effect of triac and beta-adrenergic blocking agents on the myocardium of developing rats.

Authors:  P C Pearce; C M Hawkey; C Symons; E G Olsen
Journal:  Cardiovasc Res       Date:  1983-01       Impact factor: 10.787

9.  Parathyroid hormone has a positive inotropic action in the rat.

Authors:  Y Katoh; K L Klein; R A Kaplan; W G Sanborn; K Kurokawa
Journal:  Endocrinology       Date:  1981-12       Impact factor: 4.736

10.  Role of calcium in the induction of cardiac hypertrophy and myofibrillar disarray. Experimental studies of a possible cause of hypertrophic cardiomyopathy.

Authors:  P C Pearcé; C Hawkey; C Symons; E G Olsen
Journal:  Br Heart J       Date:  1985-10
View more
  13 in total

1.  Primary hyperparathyroidism due to atypical parathyroid adenoma presenting with peroneus brevis tendon rupture.

Authors:  S Yener; A Saklamaz; T Demir; L Kebapcilar; F Bayraktar; S Canda; S Yesil
Journal:  J Endocrinol Invest       Date:  2007-05       Impact factor: 4.256

Review 2.  ABC of child abuse. Fractures.

Authors:  C J Hobbs
Journal:  BMJ       Date:  1989-04-15

3.  Premature death in patients operated on for primary hyperparathyroidism.

Authors:  G Hedbäck; L E Tisell; B A Bengtsson; I Hedman; A Oden
Journal:  World J Surg       Date:  1990 Nov-Dec       Impact factor: 3.352

Review 4.  Cardiovascular aspects of primary hyperparathyroidism.

Authors:  M D Walker; S J Silverberg
Journal:  J Endocrinol Invest       Date:  2008-10       Impact factor: 4.256

5.  Normocalcemia and persistent elevated serum concentrations of 1-84 parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of increased morbidity from cardiovascular disease.

Authors:  Henrik Vestergaard; Lars ØStergaard Kristensen
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

6.  Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data.

Authors:  F Längle; C Abela; J Koller-Strametz; M Mittelböck; J Bergler-Klein; T Stefenelli; W Woloszczuk; B Niederle
Journal:  World J Surg       Date:  1994 Jul-Aug       Impact factor: 3.352

7.  Familial neurofibromatosis and hypertrophic cardiomyopathy.

Authors:  A P Fitzpatrick; R W Emanuel
Journal:  Br Heart J       Date:  1988-09

Review 8.  Primary hyperparathyroidism and hypertension.

Authors:  Sarah B Fisher; Nancy D Perrier
Journal:  Gland Surg       Date:  2020-02

9.  Survival after parathyroidectomy in patients with end-stage renal disease and severe hyperparathyroidism.

Authors:  Andrea Trombetti; Catherine Stoermann; John H Robert; François R Herrmann; Pietra Pennisi; Pierre-Yves Martin; René Rizzoli
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

10.  The subaortic tendon as a mimic of hypertrophic cardiomyopathy.

Authors:  James Ker
Journal:  Cardiovasc Ultrasound       Date:  2009-07-03       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.